Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 123

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 4
Chunk 123
---
mann as the Company’s Interim Chief Financial Officer will be revisited by the Compensation Committee and the Board and
disclosed to the market in the future. The foregoing summary of Mr. Ellspermann’s employment agreement is qualified in its entirety
by reference to the full text of the employment agreement, which is filed as Exhibit 10.5 hereto and incorporated herein by reference.

38

Item 6. Exhibits 

    No.
     
    Description 

    10.1
     
    Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 10, 2025)  

    10.2
     
    Form of Securities Purchase Agreement, dated June 27, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.3
     
    Form of Placement Agency Agreement, dated June 27, 2025 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.4
     
    Severance Agreement, dated August 4, 2025, between INmune Bio Inc. and Raymond J. Tesi†* 

    10.5
     
    Employment Agreement, dated December 16, 2021, between INmune Bio Inc. and Cory Ellspermann†*

    31.1
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer*

    31.2
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*

    32.1
     
    Section 1350 Certification of Principal Executive Officer**

    32.2
     
    Section 1350 Certification of Chief Financial Officer**

    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF